PMGC HOLDINGS INC. Unsecured Debt
PMGC HOLDINGS INC. (ELAB) had Unsecured Debt of $53.35 thousand as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:UnsecuredDebt · last filed 2025-08-13
- 2025-06-30: Unsecured Debt $53.35K.
- 2025-03-31: Unsecured Debt $193.34K.
- 2024-12-31: Unsecured Debt $227.75K.
- 2024-03-31: Unsecured Debt $227.75K.
| Period end | Unsecured Debt |
|---|---|
| 2025-06-30 | $53.35K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $193.34K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $227.75K 10-Q · filed 2025-08-13 |
| 2024-03-31 | $227.75K 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |